The Clorox Company (CLX) Citi’s 2026 Global Consumer & Retail Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Citi’s 2026 Global Consumer & Retail Conference 2026 summary
9 Mar, 2026Transformation progress and operational updates
ERP implementation is complete, reducing cost complexity and enabling future benefits.
Strong plans for the back half of the year focus on sequential organic sales growth and execution.
Innovation pipeline and digital foundation are expected to modernize capabilities and reinforce competitive advantage.
GOJO acquisition expands leadership in health and hygiene, structurally improving growth and financial performance.
Category performance and market dynamics
U.S. retail categories expected to remain flat to 1% growth for the year, below historical averages.
Value-seeking consumer behavior is compressing categories, but no structural changes are observed.
Everyday essential categories maintain consistent wallet share, with no significant trade-down to private label.
GOJO acquisition adds categories growing at mid-single digits, enhancing overall growth.
Category-specific strategies and innovation
Litter business undergoing a full relaunch with new formulations, packaging, and digital experience to regain market share.
Trash bags category leverages RGM and innovation, including the LeakGuard line, to improve share and consumption.
Cleaning business sees strong momentum with the Clorox PURE launch targeting allergy sufferers, supported by significant marketing investment.
Innovation expected to drive shelf space gains, with most benefits realized in the fourth quarter.
Latest events from The Clorox Company
- Digital and portfolio advances, plus GOJO acquisition, drive growth and health & hygiene scale.CLX
Consumer Analyst Group of New York Conference (CAGNY) 202619 Feb 2026 - Q2 sales and EPS fell; GOJO deal and innovation aim to offset ongoing cost and market headwinds.CLX
Q2 20263 Feb 2026 - ERP-driven margin and EPS gains in FY25 reverse in FY26, with innovation to support recovery.CLX
Q4 20253 Feb 2026 - Margin expansion and portfolio reshaping drive FY24 results and FY25 outlook.CLX
Q4 20242 Feb 2026 - Recovery, margin growth, and digital innovation drive strong outlook post-cyberattack.CLX
2024 dbAccess Global Consumer Conference31 Jan 2026 - $2.25B acquisition expands health & hygiene leadership, with $50M+ in synergies expected.CLX
M&A announcement22 Jan 2026 - Recovery, portfolio shifts, and digital upgrades set the stage for renewed growth in 2025.CLX
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Sales and margins rebounded, with EPS up 371% and FY25 outlook raised post-cyberattack.CLX
Q1 202517 Jan 2026 - Q2 sales fell 15% but EPS more than doubled; Glad JV to end, FY25 outlook raised.CLX
Q2 20259 Jan 2026